Therapeutic Innovation Australia is a national consortium of translational research
infrastructure.
Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products.
​
The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.
13 July 2020
​
​
UQ COVID-19 vaccine: Research effort moved out of the lab and into human trials.
​
The human testing of the “molecular clamp” COVID-19 vaccine candidate have begun today, following encouraging results from animal testing trials. The research team includes Prof Paul Young, Prof Trent Munro (NBF Qld Node),
Dr Keith Chappell and Dr Daniel Watterson
